In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes
- PMID: 24215461
- DOI: 10.1111/1348-0421.12109
In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes
Abstract
To investigate the antifungal drug susceptibility of fungi responsible for dermatomycoses, minimum inhibition concentration (MIC) tests were performed in 44 strains of dermatophytes, including Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton tonsurans, Microsporum canis, Microsporum gypseum and Epidermophyton floccosum, with six antifungal drugs (amorolfine, terbinafine, butenafine, ketoconazole, itraconazole and bifonazole) by broth microdilution assay according to Clinical Laboratory Standard Institute protocols. Six possible dermatomycosis-causing non-dermatophytic fungi were also tested. The two major causes of tinea, T. rubrum and T. mentagrophytes, showed significantly different sensitivities to ketoconazole and bifonazole. Clinically derived dermatophytes were sensitive to the six antifungal drugs tested. However, non-dermatophytes, especially Fusarium spp., tended to be resistant to these antifungal drugs. In Trichophyton spp., the MICs of non-azole drugs had narrower distributions than those of azoles. To evaluate the effects of antifungal drug combinations, the fractional inhibitory concentration index was calculated for the combination of amorolfine and itraconazole as representative external and internal drugs for dermatophytes. It was found that this combination had synergistic or additive effects on most dermatophytes, and had no antagonistic effects. The variation in susceptibility of clinically derived fungal isolates indicates that identification of causative fungi is indispensable for appropriately choosing effective antifungal drugs in the early stages of infection. The results of combination assay suggest that multiple drugs with different antifungal mechanisms against growth of dermatophytes should be used to treat refractory dermatomycoses, especially onychomycosis.
Keywords: Trichophyton mentagrophytes; Trichophyton rubrum; antifungal combination; fractional inhibitory concentration index.
© 2013 The Societies and Wiley Publishing Asia Pty Ltd.
Similar articles
-
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.Int J Dermatol. 2013 Dec;52(12):1557-60. doi: 10.1111/ijd.12100. Epub 2013 Oct 18. Int J Dermatol. 2013. PMID: 24134487
-
In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity.Br J Dermatol. 2003 Aug;149(2):296-305. doi: 10.1046/j.1365-2133.2003.05418.x. Br J Dermatol. 2003. PMID: 12932235
-
Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method.Indian J Med Microbiol. 2015 Oct-Dec;33(4):533-7. doi: 10.4103/0255-0857.167341. Indian J Med Microbiol. 2015. PMID: 26470960
-
How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.Clin Microbiol Infect. 2021 Jan;27(1):55-60. doi: 10.1016/j.cmi.2020.08.042. Epub 2020 Sep 8. Clin Microbiol Infect. 2021. PMID: 32916260 Review.
-
An update on the myriad antifungal resistance mechanisms in dermatophytes and the place of experimental and existential therapeutic agents for Trichophyton complex implicated in tinea corporis and cruris.Expert Rev Anti Infect Ther. 2023 Jul-Dec;21(9):977-991. doi: 10.1080/14787210.2023.2250555. Epub 2023 Aug 29. Expert Rev Anti Infect Ther. 2023. PMID: 37606343 Review.
Cited by
-
Population differentiation, antifungal susceptibility, and host range of Trichophyton mentagrophytes isolates causing recalcitrant infections in humans and animals.Eur J Clin Microbiol Infect Dis. 2020 Nov;39(11):2099-2113. doi: 10.1007/s10096-020-03952-2. Epub 2020 Jun 30. Eur J Clin Microbiol Infect Dis. 2020. PMID: 32607909 Free PMC article.
-
Morpho-Molecular Characterization of Soil Inhabitant Dermatophytes from Ahvaz, Southwest of Iran, a High Occurrence of Microsporum fulvum.Mycopathologia. 2017 Aug;182(7-8):691-699. doi: 10.1007/s11046-017-0116-x. Epub 2017 Jan 20. Mycopathologia. 2017. PMID: 28108868
-
Antifungal Activity of Melaleuca alternifolia Essential Oil (TTO) and Its Synergy with Itraconazole or Ketoconazole against Trichophyton rubrum.Molecules. 2021 Jan 17;26(2):461. doi: 10.3390/molecules26020461. Molecules. 2021. PMID: 33477259 Free PMC article.
-
In Vitro Antifungal Activity of Novel Triazole Efinaconazole and Five Comparators against Dermatophyte Isolates.Antimicrob Agents Chemother. 2018 Apr 26;62(5):e02423-17. doi: 10.1128/AAC.02423-17. Print 2018 May. Antimicrob Agents Chemother. 2018. PMID: 29530856 Free PMC article.
-
In Vitro Combination Effect of Topical and Oral Anti-Onychomycosis Drugs on Trichophyton rubrum and Trichophyton interdigitale.J Fungi (Basel). 2021 Mar 12;7(3):208. doi: 10.3390/jof7030208. J Fungi (Basel). 2021. PMID: 33809181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous